Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease - Wikidata - wikimedia - TriplyDB

Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease

Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease

http://www.wikidata.org/entity/Q36512300

about

START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection HIV-associated large-vessel vasculopathy: a review of the current and emerging clinicopathological spectrum in vascular surgical practice Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus Development of imaging techniques to study the pathogenesis of biosafety level 2/3 infectious agents HIV infection and abnormal regional ventricular function HIV protease inhibitor exposure predicts cerebral small vessel disease.Non-communicable diseases and related risk behaviors among men and women living with HIV in Cambodia: findings from a cross-sectional study Virus vasculopathy and stroke: an under-recognized cause and treatment target.Magnitude and risk factors of non-communicable diseases among people living with HIV in Tanzania: a cross sectional study from Mbeya and Dar es Salaam regions Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems.T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.Stimulating high impact HIV-related cardiovascular research: recommendations from a multidisciplinary NHLBI Working Group on HIV-related heart, lung, and blood disease.Acute Spontaneous Coronary Artery Thrombosis as Initial Presentation of HIV Infection in a Young Man.The contribution of HIV infection to intracranial arterial remodeling: a pilot study.A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults.Vascular smooth muscle cells contribute to APOL1-induced podocyte injury in HIV milieu HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking.Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study.Infection and Atherosclerosis Development Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.HIV infection and stroke: current perspectives and future directions HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda.HIV stroke risk: evidence and implications.Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States.Perinatally HIV-infected youth presenting with acute stroke: progression/evolution of ischemic disease on neuroimaging.HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes.Regulation by reversible S-glutathionylation: molecular targets implicated in inflammatory diseases.Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection.Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men.Brain large artery inflammation associated with HIV and large artery remodeling.The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro.A quantitative perspective to the study of brain arterial remodeling of donors with and without HIV in the Brain Arterial Remodeling Study (BARS).Microvesicles in health and disease.HIV medications: an update and review of metabolic complications.The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease.Aging, Health, and Quality of Life for Older People Living With HIV in Sub-Saharan Africa: A Review and Proposed Conceptual Framework.HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: a case series.Dysregulation of Mitochondrial Bioenergetics and Quality Control by HIV-1 Tat in Cardiomyocytes.Metalloproteinases and Brain Arterial Remodeling Among Individuals With and Those Without HIV Infection.

P2860

Q26753830-CFEF5D29-6527-48FF-A5E2-ED9F5B86E9FB Q26824585-8686169E-35B2-45FA-85CD-8EA1077E3A6D Q26851535-8D9637DE-BCAE-4710-B43D-98BB8F683C9B Q26999176-0B93EF2E-E433-4B46-B005-EEFACEA6BA91 Q33604069-E333FF09-00FE-4222-97A9-2E8C759A6845 Q33807507-F30CC6DA-CA67-4F2D-8D2B-113C516D4DFE Q33909993-B0BA2323-C9C9-4725-82CD-5A7874395B4F Q34015853-9C068EB0-3ED0-4BC9-B091-221363CDE734 Q34168721-0D5F8CBF-A70E-40D2-829E-23CDB2B4A870 Q34730407-18CF1420-5739-44F4-A64F-FE279EB208C6 Q34764361-D3ED56E3-96CA-4A64-9734-B86A4880DEA7 Q35089263-68845201-584D-4B3E-A4E6-7A2566AD0345 Q35187972-4CB7DD39-4D9A-4DAA-940D-D455B9EA4450 Q35297689-885A47B2-AE5C-4AEA-8B78-A8B48D26EFDE Q35508301-0B994424-1C81-47D0-BAF6-7B6CE209E4F0 Q35612283-797ED26A-42D5-41C6-A633-668CD743DB32 Q35848134-83FF3618-E23B-427A-9B62-6BE8A2548954 Q35911343-3AF95F4C-3A78-4797-890F-8514D73C73C1 Q35915081-FB07F461-0AC8-4F5A-B3D1-29D8EC0FCBBA Q36104762-A73547A0-8F4C-494C-B7BA-353D5E44C48E Q36285922-FA4EFE3F-EE41-4C4F-8FC5-9E9AB5DDBB97 Q36522679-6C063552-2D47-4A07-8748-8D624989538A Q36722756-03D0E12E-7EB7-428B-BBF6-2CC3F79A5915 Q36937890-E0B4AA98-474C-4167-A79B-86F9F36B189F Q37051085-828BE078-708F-4875-BFE8-85DE43E5725A Q37090689-D5A4A749-95B0-4308-ADBE-D87A909E0DD2 Q37104590-BC4DA69B-704C-4397-9F3C-CCDD39FA88BA Q37165144-6B1C24A8-4B50-4939-8132-B5E670B51192 Q37387607-AE0046AC-3225-47FB-BEE1-759CC9CF8292 Q37393465-4134434E-C27D-426A-8235-57868D7FD9C8 Q37547729-6FDE9307-361A-4C50-962C-D0C83ADB2298 Q37591226-00B059F3-5D4E-427A-9FB8-430E7E984B91 Q37592093-5C2F3FEF-0C0A-4372-AAEC-2D04DB9A32AC Q37981578-F47FEC6D-AFC4-4A43-9F1E-3ED9C7426F2F Q37981602-B9ACAB31-15ED-4DF8-98C7-7D3BCF8BCD86 Q38223391-186A79BE-E1F4-4B6D-BD5E-E55AF5C65EEC Q38368637-7F5BC96E-D563-49AC-AD87-0147F08A7059 Q39991623-E668B874-275D-4D26-9A87-B838CBF421DB Q40206046-FBF2B7FB-A5E8-4EF7-9D13-B8CECDF74351 Q40567124-51B3A977-AF85-475C-B906-131837D1F149

P2860

Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease

http://www.wikidata.org/entity/Q36512300

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Human immunodeficiency virus ( ...... HIV-mediated vascular disease

@ast

Human immunodeficiency virus ( ...... HIV-mediated vascular disease

@en

type

label

Human immunodeficiency virus ( ...... HIV-mediated vascular disease

@ast

Human immunodeficiency virus ( ...... HIV-mediated vascular disease

@en

prefLabel

Human immunodeficiency virus ( ...... HIV-mediated vascular disease

@ast

Human immunodeficiency virus ( ...... HIV-mediated vascular disease

@en

P1433

Q36512300-56726CAC-5180-4684-B181-FD087077D345

P1476

Q36512300-1208232E-EEDC-4F7A-BD66-B8B9EBE5D796

P2093

Q36512300-25419E11-48F8-4239-A81A-B2A90322FA1C

Q36512300-398CCCA8-DEB4-4226-BE75-8B39FC08254E

Q36512300-79AC2BE2-2330-41C8-92B3-A90E1B565496

Q36512300-9C05B0E9-8605-4F49-A2E6-0C63FBC0383D

Q36512300-CA6CB8EC-9AA1-4516-BEFC-5BF2F8BE83EF

Q36512300-F5CB4C63-731A-44BF-92C3-66F928EE73F8

P2860

Q36512300-0060C36D-FBD9-493D-8758-F9F893A044E2

Q36512300-15FD2B90-6BFB-40B9-8079-4E86BBCA9C7C

Q36512300-1989488A-B7C6-47D2-ABCA-ECAC12F43091

Q36512300-1C33875A-2657-4C61-A705-9E0827D67BC3

Q36512300-1FAD7D47-AE24-426E-BCAE-B0DAE554FA68

Q36512300-21EE6353-439C-4A48-AA20-CBCC7D9F9DE8

Q36512300-2875FB2E-2D28-4887-98F7-EB44348F45D3

Q36512300-399B489D-35D3-4E04-B42F-50D206AE5A41

Q36512300-3AD066D2-6654-4986-8B45-8B09E43D9BFC

Q36512300-3BEDAC4E-52CF-46C2-9C4C-C14E5282AE5E

P304

Q36512300-ACB98391-872C-4106-A1B2-D408BD08D014

P31

Q36512300-EA66EECF-DDB1-4290-B1EC-CFB72CB04548

P356

Q36512300-5B42DCDE-7E5D-40A0-B150-42BC0766FE68

P407

Q36512300-FABAA94F-882E-4E5C-85B7-47CBD549FE3F

P433

Q36512300-7DC8F7DC-CE78-4CAC-96C2-BE125ADAD511

P478

Q36512300-A756CECB-9F64-412C-9378-3F941A94BD54

P50

Q36512300-CD700414-C549-4702-A66F-7B8638ECC248

P577

Q36512300-679FC375-3287-4A9F-B9D2-2E382AEE62B4

P5875

Q36512300-69B8FFD1-A314-47C0-B46B-0E19B37EFCF7

P698

Q36512300-D8BBB538-C300-4E00-B12C-6D230596FF1A

P932

Q36512300-8BCB08B9-B6E5-4078-8DB1-E1D30540CE1B

P356

AJPATH.2008.070457

P1433

The American Journal of Pathology

P1476

Human immunodeficiency virus ( ...... HIV-mediated vascular disease

@en

P2093

Alison D Schecter

http://www.w3.org/2001/XMLSchema#string

Arevik Mosoian

http://www.w3.org/2001/XMLSchema#string

Eliseo A Eugenin

http://www.w3.org/2001/XMLSchema#string

Joan W Berman

http://www.w3.org/2001/XMLSchema#string

Mary E Klotman

http://www.w3.org/2001/XMLSchema#string

Patrick A Lento

http://www.w3.org/2001/XMLSchema#string

P2860

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.

Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

HIV envelope gp120 activates human arterial smooth muscle cells.

Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.

Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection

Endocytosis is a critical step in entry of subgroup B avian leukosis viruses.

Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways

Immune mechanisms in atherosclerosis.

Cardiovascular disease risk factors in HIV-infected patients in the HAART era.

P304

1100-1111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2353/AJPATH.2008.070457

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5540842

http://www.w3.org/2001/XMLSchema#string

P698

18310503

http://www.w3.org/2001/XMLSchema#string

P932

2276423

http://www.w3.org/2001/XMLSchema#string